Open-label salsalate for the treatment of pre-diabetes in people with schizophrenia

Schizophr Res. 2013 Jul;147(2-3):408-9. doi: 10.1016/j.schres.2013.04.028. Epub 2013 May 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Cytokines / metabolism
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Dose-Response Relationship, Drug
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Male
  • Middle Aged
  • Prediabetic State / chemically induced*
  • Psychiatric Status Rating Scales
  • Salicylates / adverse effects*
  • Schizophrenia / drug therapy*
  • Triglycerides / metabolism
  • Young Adult

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines
  • Glycated Hemoglobin A
  • Salicylates
  • Triglycerides
  • hemoglobin A1c protein, human
  • salicylsalicylic acid